Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017

In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Sheena G, Chilver, Monique B, Carville, Kylie S, Deng, Yi-Mo, Grant, Kristina A, Higgins, Geoff, Komadina, Naomi, Leung, Vivian KY, Minney-Smith, Cara A, Teng, Don, Tran, Thomas, Stocks, Nigel, Fielding, James E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718387/
https://www.ncbi.nlm.nih.gov/pubmed/29090681
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707
_version_ 1783284309709291520
author Sullivan, Sheena G
Chilver, Monique B
Carville, Kylie S
Deng, Yi-Mo
Grant, Kristina A
Higgins, Geoff
Komadina, Naomi
Leung, Vivian KY
Minney-Smith, Cara A
Teng, Don
Tran, Thomas
Stocks, Nigel
Fielding, James E
author_facet Sullivan, Sheena G
Chilver, Monique B
Carville, Kylie S
Deng, Yi-Mo
Grant, Kristina A
Higgins, Geoff
Komadina, Naomi
Leung, Vivian KY
Minney-Smith, Cara A
Teng, Don
Tran, Thomas
Stocks, Nigel
Fielding, James E
author_sort Sullivan, Sheena G
collection PubMed
description In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.
format Online
Article
Text
id pubmed-5718387
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-57183872017-12-18 Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017 Sullivan, Sheena G Chilver, Monique B Carville, Kylie S Deng, Yi-Mo Grant, Kristina A Higgins, Geoff Komadina, Naomi Leung, Vivian KY Minney-Smith, Cara A Teng, Don Tran, Thomas Stocks, Nigel Fielding, James E Euro Surveill Rapid Communication In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons. European Centre for Disease Prevention and Control (ECDC) 2017-10-26 /pmc/articles/PMC5718387/ /pubmed/29090681 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707 Text en This article is copyright of The Authors, 2017. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Sullivan, Sheena G
Chilver, Monique B
Carville, Kylie S
Deng, Yi-Mo
Grant, Kristina A
Higgins, Geoff
Komadina, Naomi
Leung, Vivian KY
Minney-Smith, Cara A
Teng, Don
Tran, Thomas
Stocks, Nigel
Fielding, James E
Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title_full Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title_fullStr Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title_full_unstemmed Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title_short Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017
title_sort low interim influenza vaccine effectiveness, australia, 1 may to 24 september 2017
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718387/
https://www.ncbi.nlm.nih.gov/pubmed/29090681
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.43.17-00707
work_keys_str_mv AT sullivansheenag lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT chilvermoniqueb lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT carvillekylies lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT dengyimo lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT grantkristinaa lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT higginsgeoff lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT komadinanaomi lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT leungvivianky lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT minneysmithcaraa lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT tengdon lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT tranthomas lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT stocksnigel lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017
AT fieldingjamese lowinteriminfluenzavaccineeffectivenessaustralia1mayto24september2017

Ejemplares similares